GlassScriptPhysician profile
Kacy D Pate
NPI 1356386791
$396.34
in general payments reported to CMS, 2019-2025
11 companies · $44.67 in 2025
The $44.67 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.96 · 2020: $42.46 · 2021: $66.42 · 2022: $34.67 · 2023: $121 · 2024: $73.12 · 2025: $44.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $113.03 | 2022-2024 | Cequa |
| Allergan, INC. | $60.45 | 2020-2022 | |
| Alcon Vision LLC | $46.01 | 2023-2025 | Rocklatan |
| Novartis Pharmaceuticals Corporation | $34.58 | 2019-2020 | |
| Rxsight INC | $31.22 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Abbvie INC. | $23.57 | 2025 | |
| Sight Sciences, INC. | $22.82 | 2023 | Omni Surgical System |
| Kala Pharmaceuticals, INC. | $17.13 | 2021 | |
| Amgen INC. | $16.72 | 2024 | Tepezza |
| Aerie Pharmaceuticals, INC. | $16.01 | 2021 | |
| Glaukos Corporation | $14.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kacy Pate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.